Contact Us

PW Case Review Form
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 

Phone 

   * Please describe your case:

What injury have you suffered?

For verification purposes, please answer the below question:
+
=

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.


Nationwide Alert Concerning All Injectable Drugs Prepared By Urgent Care Pharmacy

Nov 18, 2002 | FDA.GOV The Food and Drug Administration (FDA) announced a nationwide alert
concerning all injectable drugs prepared by Urgent Care Pharmacy of
Spartanburg, South Carolina, based on the lack of assurance that their
products are sterile. Non-sterility of injectable products can represent a
serious hazard to health that could lead to life-threatening injuries and
death. FDA inspection of Urgent Care's facility revealed the firm failed to
have adequate controls to ensure necessary sterility, including the absence
of appropriate testing for potency and sterility prior to distribution.

FDA is aware that Urgent Care has distributed the following injectable drugs
to physicians, hospitals, clinics and consumers in Connecticut, Illinois,
Indiana, Kentucky, Louisiana, Massachusetts, Mississippi, New Hampshire,
North Carolina, South Carolina and Virginia: Baclofen, Betamethasone, Bimix
30:1, (Phentolamine mesylate/papaverine), Clonidine, Estradiol,
Hydromorphone HCl, Fentanyl, Methylprednisole acetate, Morphine
Sulfate/Bupivacaine, Papaverine HCl, Super Trimix (Papaverine
HCl/phentolamine mesylate/prostaglandin), Testosterone cypionate,
Testosterone/Estradiol.

Related articles
Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo